Tacoma's wellness culture drives strong interest in GLP-1 treatments. Ozempic® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method offers a separate program for Tacoma residents: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month, with the provider evaluation, the medication, ongoing care, and home delivery to Tacoma included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Tacoma is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Tacoma, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Ozempic® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2017 for Type 2 diabetes. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Tacoma residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
City life in Tacoma brings convenience in many forms, but it also brings sedentary desk jobs, food delivery temptation, and stress-driven eating patterns that make weight management difficult. Semaglutide therapy works at the biological level — reducing hunger and cravings — so Tacoma residents can make better choices even during their busiest days. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month through virtual consultations that fit into a lunch break. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Ozempic from $199/month.
Get Started NowFree consultation. No commitment.